William Bozza, PhD

Billy Bozza joined the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute in January of 2021.  He serves as a Program Director, managing a portfolio of oncology startups (SBIR & STTR awardees) to facilitate small businesses in technology commercialization for cancer diagnosis and treatment.  Billy is currently leading the Center’s efforts on the Small Business Concept Award for early-stage high risk/high reward technologies that are targeting rare and pediatric cancers.  He is also taking the lead on the Program’s Peer Learning and Networking Webinar Series to help SBIR companies learn from peers and facilitate collaboration. 

Billy received his doctorate in Biochemistry in 2013 from the University of Delaware, where he was trained as an enzymologist.  Before joining NCI, Billy previously served as a Regulatory Scientist at FDA specializing in chemistry, manufacturing, and control (CMC) review of drug applications.